328 related articles for article (PubMed ID: 19835554)
1. Pharmacogenetics of drug transporters.
Franke RM; Gardner ER; Sparreboom A
Curr Pharm Des; 2010; 16(2):220-30. PubMed ID: 19835554
[TBL] [Abstract][Full Text] [Related]
2. Role of OATP transporters in the disposition of drugs.
Niemi M
Pharmacogenomics; 2007 Jul; 8(7):787-802. PubMed ID: 18240907
[TBL] [Abstract][Full Text] [Related]
3. Intestinal efflux transporters and drug absorption.
Murakami T; Takano M
Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):923-39. PubMed ID: 18624680
[TBL] [Abstract][Full Text] [Related]
4. ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
Bruckmueller H; Cascorbi I
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):369-396. PubMed ID: 33459081
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
Huang Y
Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
[TBL] [Abstract][Full Text] [Related]
6. Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.
Kivistö KT; Niemi M
Pharm Res; 2007 Feb; 24(2):239-47. PubMed ID: 17177112
[TBL] [Abstract][Full Text] [Related]
7. Drug transporters in drug efficacy and toxicity.
DeGorter MK; Xia CQ; Yang JJ; Kim RB
Annu Rev Pharmacol Toxicol; 2012; 52():249-73. PubMed ID: 21942630
[TBL] [Abstract][Full Text] [Related]
8. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.
Cascorbi I
Pharmacol Ther; 2006 Nov; 112(2):457-73. PubMed ID: 16766035
[TBL] [Abstract][Full Text] [Related]
9. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
Bruhn O; Cascorbi I
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of efflux drug transporters in the intestine.
Takano M; Yumoto R; Murakami T
Pharmacol Ther; 2006 Jan; 109(1-2):137-61. PubMed ID: 16209890
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of membrane transporters: a review of current approaches.
Sissung TM; Gardner ER; Gao R; Figg WD
Methods Mol Biol; 2008; 448():41-62. PubMed ID: 18370230
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Leslie EM; Deeley RG; Cole SP
Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
[TBL] [Abstract][Full Text] [Related]
14. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
15. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
Albermann N; Schmitz-Winnenthal FH; Z'graggen K; Volk C; Hoffmann MM; Haefeli WE; Weiss J
Biochem Pharmacol; 2005 Sep; 70(6):949-58. PubMed ID: 16054595
[TBL] [Abstract][Full Text] [Related]
16. The genetic polymorphism of drug transporters: functional analysis approaches.
Ishikawa T; Tsuji A; Inui K; Sai Y; Anzai N; Wada M; Endou H; Sumino Y
Pharmacogenomics; 2004 Jan; 5(1):67-99. PubMed ID: 14683421
[TBL] [Abstract][Full Text] [Related]
17.
Anderson LL; Etchart MG; MacNair L; Land MH; Mosesova IA; Bonn-Miller MO; Arnold JC
Cannabis Cannabinoid Res; 2022 Jun; 7(3):304-317. PubMed ID: 33998860
[No Abstract] [Full Text] [Related]
18. Organic anion-transporting polypeptide 1B1 mediates transport of Gimatecan and BNP1350 and can be inhibited by several classic ATP-binding cassette (ABC) B1 and/or ABCG2 inhibitors.
Oostendorp RL; van de Steeg E; van der Kruijssen CM; Beijnen JH; Kenworthy KE; Schinkel AH; Schellens JH
Drug Metab Dispos; 2009 Apr; 37(4):917-23. PubMed ID: 19139163
[TBL] [Abstract][Full Text] [Related]
19. The reference liver - ABC and SLC drug transporters in healthy donor and metastatic livers.
Kurzawski M; Szeląg-Pieniek S; Łapczuk-Romańska J; Wrzesiński M; Sieńko J; Oswald S; Droździk M
Pharmacol Rep; 2019 Aug; 71(4):738-745. PubMed ID: 31207436
[TBL] [Abstract][Full Text] [Related]
20. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
Patel M; Taskar KS; Zamek-Gliszczynski MJ
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
